Pioneering Research for Tomorrow's World

Virology and Viral Evolution: Educational Resource

Understanding how viruses evolve, spread, and cause disease — from basic biology to pandemic science

Virology is the branch of microbiology concerned with viruses — submicroscopic, non-cellular agents that replicate only inside the living cells of organisms. Viruses infect all life forms, from animals and plants to fungi and bacteria. The study of viruses is fundamental to medicine, public health, evolutionary biology, and biotechnology.

Virus Structure and Classification

All viruses share certain structural features. At minimum, a virus consists of genetic material (either DNA or RNA) enclosed in a protein coat called a capsid. Many viruses also have an outer lipid membrane (envelope) derived from the host cell membrane. The combination of capsid and envelope (if present) is called the virion — the extracellular, infectious form of the virus.

Viruses are classified by several criteria:

• Genome type: DNA or RNA; single-stranded (ss) or double-stranded (ds); positive-sense (+), negative-sense (-), or ambisense RNA
• Capsid symmetry: Icosahedral, helical, or complex
• Presence of envelope: Enveloped or non-enveloped
• Size: Ranging from ~20 nm (parvoviruses) to >1 micrometer (pandoraviruses)
• Host range: Animal viruses, plant viruses, bacteriophages (infect bacteria), archaeal viruses

Coronaviruses and SARS-CoV-2

Coronaviruses (family Coronaviridae) are enveloped, positive-sense, single-stranded RNA viruses with the largest known RNA genomes (~26–32 kilobases). They derive their name from the crown-like appearance of their surface spike proteins under electron microscopy (Latin: corona = crown). Seven human coronaviruses are known:

• Common cold coronaviruses: HCoV-229E, HCoV-OC43, HCoV-NL63, HCoV-HKU1 — cause mild upper respiratory infections in most people
• Severe disease coronaviruses: SARS-CoV (2002-03 SARS pandemic), MERS-CoV (ongoing in Middle East), SARS-CoV-2 (COVID-19 pandemic, 2019-present)

SARS-CoV-2, the causative agent of COVID-19, uses its spike protein's receptor-binding domain to attach to ACE2 (angiotensin-converting enzyme 2) receptors on human cells. Once attached, the spike protein undergoes conformational changes that fuse viral and host cell membranes, allowing viral RNA to enter the cytoplasm. The positive-sense RNA is directly translated by host ribosomes to produce viral proteins, including the RNA-dependent RNA polymerase (RdRp) that replicates the viral genome.

Viral Evolution and Variant Emergence

RNA viruses mutate rapidly because RNA polymerases lack proofreading mechanisms, introducing approximately one error per 10,000 nucleotides copied. For SARS-CoV-2 with its ~30,000 nucleotide genome, this means roughly one to three mutations per replication cycle. Most mutations are deleterious or neutral, but occasionally a mutation confers a replicative advantage — higher ACE2 binding affinity, faster replication, better immune evasion, or more efficient transmission. Such advantageous mutations are amplified by natural selection, potentially giving rise to new variants.